Antioxidant and Anti-hyperlipidemic Effects of Bark Extract of Pinus eldarica in Dexamethasone-induced Dyslipidemic Rats

سال انتشار: 1398
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 195

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ZUMS-27-125_007

تاریخ نمایه سازی: 11 اردیبهشت 1400

چکیده مقاله:

Background & Objective: Although Pinus eldarica is considered as a pine with many valuable phytochemical constituents, little is known about the pharmacological effects of its bark extract. Therefore, the present study aimed to evaluate in vivo antioxidant activity and also the possible beneficial effects of the bark extract of P. eldarica on dexamethasone-induced dyslipidemia in rats. Materials & Methods: Total phenolic content was determined using Folin-Ciocalteu method. The in vivo antioxidant assays included the measurement of hydroperoxides level and ferric reducing antioxidant power (FRAP) value in plasma samples of rats receiving intraperitoneal injections (IP) injections of plant extract (۱۰۰, ۲۰۰ and ۴۰۰ mg/kg) for ۲۸ days. For induction of dyslipidemia, dexamethasone (۱۰ mg/kg) was subcutaneously administered during ۸ days. Different doses of extract were given orally plus dexamethasone in three groups of animals. Serum lipids, blood glucose and malondialdehyde (MDA) levels and liver histopathology were assessed. Results: High total phenolic content was determined as ۳۷۵±۱.۲ mg gallic acid equivalent/ g of dried bark extract. The extract significantly decreased plasma hydroperoxides level at all doses and increased FRAP value at the dose of ۴۰۰ mg/kg during in vivo antioxidant analysis. P. eldarica led to a significant reduction in serum levels of blood glucose, total cholesterol, triglyceride and MDA and improved liver histopathological changes at the doses of ۲۰۰ and ۴۰۰ mg/kg in dyslipidemic rats. Conclusion: These findings suggest the potential antioxidant, antihyperlipidemic and antihyperglycemic activities for the bark extract of P. eldarica which may be due to the high amounts of phenolic compounds.

نویسندگان

Leila Safaeian

Department of Pharmacology and Toxicology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Behzad Zolfaghari

Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Najmeh Assarzadeh

Department of Pharmacology and Toxicology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Akram Ghadirkhomi

Office for Supervision on Food, Cosmetics and Hygienic Products, Vice Chancellery for Food and Drugs, Isfahan University of Medical Sciences, Isfahan, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Shattat GF. A review article on hyperlipidemia: types, treatments and ...
  • Howard Alpe G, Sear J, Foex P. Methods of detecting ...
  • Navab M, Ananthramaiah G, Reddy ST, et al. Thematic review ...
  • Schulz E, Anter E, Keaney J, John F. Oxidative stress, ...
  • Peluso I, Morabito G, Urban L, Ioannone F, Serafi M. ...
  • Dhaliya S, Surya A, Dawn V, Betty C, Arun K, ...
  • Gernandt DS, López GG, García SO, Liston A. Phylogeny and ...
  • Mamedov N, Gardner Z, Craker LE. Medicinal plants used in ...
  • Mamedov N, Craker LE. Medicinal plants used for the treatment ...
  • Mehrzadi S, Ghaznavi H, Tajallizadehkhoob Y, Fakhrzadeh H. Effects of ...
  • Huseini HF, Anvari MS, Khoob YT, et al. Anti-hyperlipidemic and ...
  • Babaee F, Safaeian L, Zolfaghari B, Haghjoo Javanmard S. Cytoprotective ...
  • Iravani S, Zolfaghari B. Phytochemical analysis of Pinus eldarica bark. ...
  • Yegdaneh A, Ghannadi A, Dayani L. Chemical constituents and biological ...
  • Wolff SP. Ferrous ion oxidation in presence of ferric ion ...
  • Benzie IF, Strain JJ. The ferric reducing ability of plasma ...
  • Kumar VR, Inamdar MN, Nayeemunnisa, Viswanatha GL. Protective effect of ...
  • Mesripour A, Iyer A, Brown L. Mineralocorticoid receptors mediate cardiac ...
  • Bera S, Greiner S, Choudhury A, et al. Dexamethasone-induced oxidative ...
  • Pragda SS, Kuppast I, Mankani K, Ramesh L. Evaluation of ...
  • Bargi R, Asgharzadehyazdi F, BeheshtI F, et al. The effects ...
  • Sadeghi Afjeh M, Fallah Huseini H, Tajalizadekhoob Y, Mirarefin M, ...
  • Joo HE, Lee HJ, Sohn EJ, et al. Anti-diabetic potential ...
  • Liu X, Wei J, Tan F, Zhou S, Wurthwein G, ...
  • Kaushik P, Khokra S, Kaushik D. Evaluation of antidiabetic potential ...
  • El-Manawaty M, Gohar L. In vitro alpha-glucosidase inhibitory activity of ...
  • Devaraj S, Vega-Lopez S, Kaul N, Schonlau F, Rohdewald P, ...
  • Durackova Z, Trebaticky B, Novotny V, Zitnanova I, Breza J. ...
  • Kim JH, Lee HJ, Jeong SJ, Lee MH, Kim SH. ...
  • Samavat H, Newman AR, Wang R, Yuan JM, Wu AH, ...
  • Kim A, Nam YJ, Lee CS. Taxifolin reduces the cholesterol ...
  • Theriault A, Wang Q, Van Iderstine SC, Chen B, Franke ...
  • Huang DW, Shen SC, Wu JS. Effects of caffeic acid ...
  • Liao CC, Ou TT, Wu CH, Wang CJ. Prevention of ...
  • نمایش کامل مراجع